Asymmetric Total Synthesis of the Gastroprotective Microbial Agent AI-77-B
FULL PAPER
3 H), 1.57/1.52 (2 s, 3 H), 1.47 (s, 9 H) ppm. 13C NMR (CHCl3,
125 MHz): δ ϭ 200.9, 152.1/152.0, 137.1, 135.6, 129.0, 128.8, 128.4,
117.2/116.9, 94.5/93.9, 80.6, 80.5/80.3, 75.4/75.2, 72.8/72.6, 58.2,
35.2/34.8, 28.8, 28.0/27.3, 25.4/24.1 ppm. IR (film): ν˜ ϭ 1739 (s),
1696 (s) cmϪ1. LRMS (FAB, m/z): 390. HRMS (FAB, m/z): calcd.
C22H32O5N [M ϩ Hϩ] 390.2281, found 390.2287. A mixture of
(allS)-tert-butyl 4-allyl-5-(1Ј-benzyloxy-2Ј-oxoethyl)-2,2-dimethyl-
1,3-oxazolidine-3-carboxylate (0.42 g, 1.08 mmol), 2-methyl-2-but-
ene (4 mL), sodium chlorite (1.27 g, 14.0 mmol) and
NaH2PO4·H2O (1.93 g, 14.0 mmol) in tBuOH (25 mL) and water
(5 mL) was stirred for 2 h at room temperature. Saturated aqueous
NH4Cl was added, tBuOH was evaporated, and the aqueous layer
was extracted with CH2Cl2. The extract was dried with Na2SO4
and concentrated in vacuo to afford 3 (0.43 g, 98%) as a highly
viscous oil. [α]2D3 ϭ Ϫ13.2 (c ϭ 2.50, CHCl3). 1H NMR (CDCl3,
500 MHz): δ ϭ 7.35 (m, 5 H), 5.82 (m, 1 H), 5.01 (m, 2 H), 4.66
(d, J ϭ 11.0 Hz, 1 H), 4.46 (d, J ϭ 11.0 Hz, 1 H), 4.31 (m, 1.5 H),
4.12 (m, 1.5 H), 2.40Ϫ2.28 (m, 2 H), 1.60/1.57 (2 s, 3 H), 1.52/1.49
(2 s, 3 H), 1.48/1.45 (2 s, 9 H) ppm. 13C NMR (CHCl3, 125 MHz):
δ ϭ 174.9, 152.5/152.1, 136.9/136.8, 135.7, 128.9, 128.8, 128.5,
117.1/116.7, 94.4/93.9, 80.8/80.4, 76.5, 76.2/76.0, 72.8/72.6, 58.1,
35.1/34.7, 28.8, 28.0/27.3, 25.3/24.0 ppm. IR (film): ν˜ ϭ 1742 (m),
1670 (s) cmϪ1. LRMS (FAB, m/z): 406. HRMS (FAB, m/z): calcd.
C22H32O6N [M ϩ Hϩ] 406.2230, found 406.2244.
{benzyloxy[1ЈЈ-(8ЈЈЈ-methoxy-1ЈЈЈ-oxoisochroman-3ЈЈЈ-yl)-3ЈЈ-meth-
ylbutylcarbamoyl]methyl}-2,2-dimethyl-4-(2Ј-oxoethyl)-1,3-oxazol-
idine-3-carboxylate (294 mg, 98%) as a colourless oil. [α]2D3
ϭ
Ϫ105.8 (c ϭ 0.68, CHCl3). 1H NMR (CDCl3, 500 MHz): δ ϭ 9.60
(d, J ϭ 2.7 Hz, 1 H), 7.48 (dd, J ϭ 8.4, 7.6 Hz, 1 H), 7.37Ϫ7.22
(m, 5 H), 6.94 (d, J ϭ 8.5 Hz, 1 H), 6.78 (d, J ϭ 7.5 Hz, 1 H), 6.52
(m, 1 H), 4.68Ϫ4.08 (m, 6 H), 4.00 (m, 1 H), 3.98 (s, 3 H),
3.06Ϫ2.51 (m, 3 H), 1.89 (m, 2 H), 1.68 (m, 1 H), 1.48Ϫ1.30 (m,
16 H), 0.97 (d, J ϭ 8.3 Hz, 6 H) ppm. 13C NMR (CHCl3,
125 MHz): δ ϭ 200.1, 170.0/169.8, 162.5, 161.6, 151.7/150.7, 142.4,
136.5, 135.2, 129.5, 129.2, 129.0, 119.7, 113.7, 111.2, 94.4/94.0,
81.3/80.9, 80.0, 76.9, 76.6/76.1, 73.3/72.8, 56.7, 55.2, 49.2, 45.1,
41.0, 32.1, 28.7, 27.3/25.3, 25.1, 25.0/23.8, 23.5, 22.2 ppm. IR
(film): ν˜ ϭ 3311 (br), 1725 (s), 1690 (s) cmϪ1. LRMS (FAB, m/z):
653. HRMS (FAB, m/z) calcd. C36H49O9N2 [M ϩ Hϩ] 653.3438,
found 653.3458. A mixture of (allS)-tert-butyl 5-{benzyloxy-[1ЈЈ-
(8ЈЈЈ-methoxy-1ЈЈЈ-oxoisochroman-3ЈЈЈ-yl)-3ЈЈ-methylbutyl-
carbamoyl]methyl}-2,2-dimethyl-4-(2Ј-oxoethyl)-1,3-oxazolidine-3-
carboxylate (187 mg, 0.29 mmol), 2-methyl-2-butene (1 mL), so-
dium chlorite (335 mg, 3.70 mmol) and NaH2PO4·H2O (511 mg,
3.70 mmol) in tBuOH (10 mL) and water (2 mL) was stirred for 1 h
at room temperature. Saturated aqueous NH4Cl was added,
tBuOH was evaporated and the aqueous layer was extracted with
CH2Cl2. The extract was dried with Na2SO4 and concentrated in
vacuo to afford (allS)-tert-butyl 5-{benzyloxy-[1Ј-(8ЈЈ-methoxy-1ЈЈ-
oxoisochroman-3ЈЈ-yl)-3Ј-methylbutylcarbamoyl]methyl}-4-carb-
(allS)-tert-Butyl
4-Allyl-5-{benzyloxy[1Ј-(8ЈЈ-methoxy-1ЈЈ-oxoiso-
chroman-3ЈЈ-yl)-3Ј-methylbutylcarbamoyl]methyl}-2,2-dimethyl-1,3-
oxazolidine-3-carboxylate (34): Trifluoroacetic acid (10 mL) was
added at 0 °C to a solution of 2 in CH2Cl2 (40 mL). The reaction
mixture was stirred for 10 min at 0 °C and concentrated to com-
plete dryness in vacuo. A solution of 3 (402 mg, 1.00 mmol), EDCI
(190 mg, 1.00 mmol) and DMAP (484 mg, 3.96 mmol) in CH2Cl2
(25 mL) was added, and the mixture was stirred for 6 h at room
temperature. The reaction mixture was extracted with saturated
aqueous NH4Cl, dried with Na2SO4, concentrated in vacuo and
chromatographically purified (silica, 40% EtOAc in hexanes) to
give 34 (460 mg, 72%) as a white solid. M.p. 72 °C. [α]2D3 ϭ Ϫ95.4
(c ϭ 2.55, CHCl3). 1H NMR (CDCl3, 500 MHz): δ ϭ 7.48 (dd,
J ϭ 8.5, 7.5 Hz, 1 H), 7.37Ϫ7.27 (m, 4 H), 7.23 (m, 1 H), 6.93 (d,
J ϭ 8.5 Hz, 1 H), 6.78 (d, J ϭ 7.5 Hz, 1 H), 6.48 (m, 1 H), 5.81
(m, 1 H), 5.00 (m, 2 H), 4.63 (m, 1 H), 4.48 (m, 1 H), 4.43 (m, 2
H), 4.25 (m, 1.5 H), 4.06 (m, 0.5 H), 4.02 (d, J ϭ 7.9 Hz, 1 H),
3.98 (s, 3 H), 3.04 (dd, J ϭ 15.2, 13.4 Hz, 1 H), 2.72 (dd, J ϭ 15.1,
5.8 Hz, 1 H), 2.39Ϫ2.24 (m, 2 H), 1.90 (m, 1 H), 1.66 (m, 1 H),
1.48Ϫ1.31 (m, 16 H), 0.97 (m, 6 H) ppm. 13C NMR (CHCl3,
75 MHz): δ ϭ 169.9, 162.2, 161.0, 151.8/151.5, 142.0, 136.4/136.3,
135.4, 134.8, 128.7, 128.5, 128.3, 119.2, 116.5/116.1, 113.1, 110.7,
93.5/93.1, 79.9/79.7, 79.6, 76.6, 76.4/76.1, 72.3/72.1, 57.7/57.6, 56.1,
48.7, 40.5, 34.9/34.5, 31.6, 28.3, 27.5/26.8, 24.7, 24.6/23.3, 23.1,
21.7 ppm. IR (film): ν˜ ϭ 3313 (br), 1723 (s), 1691 (s) cmϪ1. LRMS
(FAB, m/z): 651. HRMS (FAB, m/z): calcd. C37H51O8N2 [M ϩ Hϩ]
651.3645, found 651.3695.
oxymethyl-2,2-dimethyl-1,3-oxazolidine-3-carboxylate
(189 mg,
99%) as a viscous oil. [α]2D3 ϭ Ϫ97.5 (c ϭ 0.41, CHCl3). H NMR
(CDCl3, 500 MHz): δ ϭ 7.47 (dd, J ϭ 8.6, 7.5 Hz, 1 H), 7.32 (d,
J ϭ 7.4 Hz, 2 H), 7.23 (dd, J ϭ 7.4, 7.2 Hz, 2 H), 7.15 (m, 1 H),
6.93 (d, J ϭ 8.5 Hz, 1 H), 6.76 (d, J ϭ 7.5 Hz, 1 H), 6.71 (m, 1 H),
4.55Ϫ4.29 (m, 5 H), 4.19 (d, J ϭ 6.6 Hz, 1 H), 3.96 (s, 3 H), 3.65
(m, 1 H), 2.90 (m, 1 H), 2.69 (m, 2 H), 2.45 (m, 1 H), 1.87 (m, 1
H), 1.69 (m, 1 H), 1.48Ϫ1.26 (m, 16 H), 0.97 (d, J ϭ 8.3 Hz, 6 H)
ppm. 13C NMR (CHCl3, 125 MHz, 315 K): δ ϭ 174.3, 170.0,
162.7, 161.6, 151.7/150.7, 142.5, 136.9, 135.2, 128.9, 128.5, 119.7,
113.8, 111.3, 93.7, 80.9/80.7, 80.0, 76.8, 74.7/73.7, 72.3, 56.6, 56.3/
56.2, 49.5, 41.0, 35.9, 32.1, 28.7, 26.8/26.7, 25.2, 23.4, 23.2/23.1,
22.3 ppm. IR (film): ν˜ ϭ 3318 (br. w), 1710 (br. s) cmϪ1. LRMS
(FAB, m/z): 691. HRMS (FAB, m/z): calcd. C36H48O10N2Na [M ϩ
Naϩ] 691.3207, found 691.3230. A solution of (allS)-tert-butyl 5-
{benzyloxy[1Ј-(8ЈЈ-methoxy-1ЈЈ-oxoisochroman-3ЈЈ-yl)-3Ј-methyl-
butylcarbamoyl]methyl}-4-carboxymethyl-2,2-dimethyl-1,3-
oxazolidine-3-carboxylate (190 mg, 0.28 mmol) and Cs2CO3
(46.0 mg, 0.142 mmol) in MeOH (10 mL) and water (2 mL) was
stirred for 30 min at room temperature. Both solvents were evapor-
ated and the resulting residue was dissolved in DMF (20 mL).
Benzyl bromide (38.0 µg, 0.28 mmol) was added, and the reaction
mixture was stirred for 12 h at room temperature. EtOAc was ad-
ded and the mixture was washed with brine. The organic layer was
dried with Na2SO4, concentrated in vacuo and chromatographic-
ally purified (silica, 50% EtOAc in hexanes) to yield 35 (193 mg,
90%) a white solid. M.p. 74 °C. [α]2D3 ϭ Ϫ83.6 (c ϭ 1.35, CHCl3).
1H NMR (CDCl3, 500 MHz): δ ϭ 7.47 (dd, J ϭ 8.5, 7.5 Hz, 1 H),
7.34Ϫ7.17 (m, 10 H), 6.94 (d, J ϭ 8.5 Hz, 1 H), 6.77 (d, J ϭ 7.5 Hz,
1 H), 6.49 (m, 1 H), 5.05Ϫ4.30 (m, 8 H), 4.14 (m, 1 H), 3.98 (s, 3
H), 3.00Ϫ2.50 (m, 4 H), 1.86 (m, 1 H), 1.72 (m, 1 H), 1.52Ϫ1.35
(m, 16 H), 0.94 (m, 6 H) ppm. 13C NMR (CHCl3, 125 MHz): δ ϭ
171.3/170.9, 169.9, 162.6, 161.5, 152.1/151.5, 142.5, 136.9/136.8,
136.5/136.1, 135.2, 128.9Ϫ128.4, 119.7, 113.7, 111.2, 93.8/93.5,
80.9/80.6, 80.0/79.9, 76.8, 76.6/76.4, 73.1/72.6, 66.9/66.8, 56.7, 56.4/
56.2, 49.3, 40.9, 36.2/35.7, 32.1, 28.8, 28.2/27.2, 25.1, 25.0/23.8,
23.4, 22.4/22.3 ppm. IR (film): ν˜ ϭ 3326 (br. w), 1733 (s), 1694 (s)
1
(allS)-tert-Butyl 4-Benzyloxycarbonylmethyl-5-{benzyloxy[1Ј-(8ЈЈ-
methoxy-1ЈЈ-oxoisochroman-3ЈЈ-yl)-3Ј-methylbutylcarbamoyl]-
methyl}-2,2-dimethyl-1,3-oxazolidine-3-carboxylate (35): A solution
of 34 (300 mg, 0.46 mmol) in CH2Cl2 (50 mL) was cooled to Ϫ78
°C. Ozone was passed through the solution until the blue colour
persisted. Oxygen and nitrogen were successively passed through
the solution for at least 10 min each. PPh3 (121 mg, 0.46 mmol)
was added portionwise under N2 and the reaction mixture was al-
lowed to warm to room temperature over a period of 1 h. Evapora-
tion of solvent and chromatographic purification (silica, 50%
EtOAc in hexanes) of the residue yielded (allS)-tert-butyl 5-
Eur. J. Org. Chem. 2003, 821Ϫ832
831